The global bispecific and multispecific antibodies market is experiencing substantial growth, driven by growing demand for innovative therapies. These antibody formats offer remarkable therapeutic advantages by simultaneously targeting two antigens, leading to enhanced efficacy and minimized side effects. Major players in the market are actively in